Bharti Research Institute of Diabetes and Endocrinology

Karnāl, Haryana 132001

0 studies enrolling now · 2 studies all time

What they study most

Diabetes, Type 2 Diabetes

Studies at this site

• Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of MBX-2982 Administered Daily for 4 Weeks as Monotherapy in Patients With Type 2 Diabetes — Completed
• A Clinical Study to Evaluate the Effect of Naturlose (Tagatose) — Completed